SANARICA, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 694
EU - Europa 133
AS - Asia 41
OC - Oceania 1
Totale 869
Nazione #
US - Stati Uniti d'America 694
IT - Italia 66
SE - Svezia 40
CN - Cina 28
GB - Regno Unito 9
VN - Vietnam 8
DE - Germania 7
FI - Finlandia 4
FR - Francia 4
IN - India 4
NL - Olanda 3
AU - Australia 1
JP - Giappone 1
Totale 869
Città #
Fairfield 120
Chandler 99
Woodbridge 60
Houston 49
Ashburn 48
Cambridge 48
Nyköping 40
Seattle 38
Wilmington 36
Bari 20
New York 14
Ann Arbor 12
Lawrence 12
Des Moines 11
Roxbury 11
Beijing 10
Inglewood 9
Dong Ket 8
Milan 7
Nanjing 6
San Diego 6
Taranto 6
Brooklyn 4
Helsinki 3
London 3
Hebei 2
Hefei 2
Los Angeles 2
Nanchang 2
Naples 2
Nulvi 2
Pune 2
Sennori 2
Seveso 2
Tianjin 2
Amsterdam 1
Chicago 1
Dearborn 1
Falkenberg 1
Gioia Del Colle 1
Hounslow 1
Jiaxing 1
Kagoya 1
Kilburn 1
Leawood 1
Liverpool 1
Messina 1
Monmouth Junction 1
Mumbai 1
Nürnberg 1
Padova 1
Princeton 1
Redwood City 1
San Francisco 1
Sassari 1
Shenyang 1
Sindelfingen 1
Sydney 1
Valenzano 1
Wuhan 1
Totale 725
Nome #
Dasatinib/HP-β-CD inclusion complex based aqueous formulation as a promising tool for the treatment of paediatric neuromuscular disorders 123
Contractile efficiency of dystrophic mdx mouse muscle: In vivo and ex vivo assessment of adaptation to exercise of functional end points 120
Effect of a long-term treatment with metformin in dystrophic mdx mice: A reconsideration of its potential clinical interest in Duchenne muscular dystrophy 109
A long-term treatment with taurine prevents cardiac dysfunction in mdx mice 95
Proof-of-concept validation of the mechanism of action of Src tyrosine kinase inhibitors in dystrophic mdx mouse muscle: in vivo and in vitro studies 89
Proteome analysis in dystrophic mdx mouse muscle reveals a drastic alteration of key metabolic and contractile proteins after chronic exercise and the potential modulation by anti-oxidant compounds 79
Dual action of mexiletine and its pyrroline derivatives as skeletal muscle sodium channel blockers and anti-oxidant compounds: Toward novel therapeutic potential 65
Ergogenic effect of bcaas and l-alanine supplementation: Proof-of-concept study in a murine model of physiological exercise 56
"Of Mice and Measures": A Project to Improve How We Advance Duchenne Muscular Dystrophy Therapies to the Clinic 43
Effect of exercise on telomere length and telomere proteins expression in mdx mice 38
Ultrasonography validation for early alteration of diaphragm echodensity and function in the mdx mouse model of Duchenne muscular dystrophy 35
BCAAs and Di-Alanine supplementation in the prevention of skeletal muscle atrophy: preclinical evaluation in a murine model of hind limb unloading 31
β‐Dystroglycan Restoration and Pathology Progression in the Dystrophic mdx Mouse: Outcome and Implication of a Clinically Oriented Study with a Novel Oral Dasatinib Formulation 29
Branched-Chain Amino Acids and Di-Alanine Supplementation in Aged Mice: A Translational Study on Sarcopenia 11
Growth hormone secretagogues modulate inflammation and fibrosis in mdx mouse model of Duchenne muscular dystrophy 8
LKB1 signaling is altered in skeletal muscle of a Duchenne muscular dystrophy mouse model 7
Data on protein abundance alteration induced by chronic exercise in mdx mice model of Duchenne muscular dystrophy and potential modulation by apocynin and taurine 4
Totale 942
Categoria #
all - tutte 4.488
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.488


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201952 0 0 0 0 0 0 0 0 0 0 27 25
2019/2020211 28 12 5 33 22 12 17 29 22 13 12 6
2020/2021216 13 9 4 34 21 4 11 13 19 43 27 18
2021/2022107 13 0 3 0 0 10 9 0 11 10 20 31
2022/2023225 16 34 15 23 23 23 1 26 39 4 11 10
2023/202483 5 20 3 11 8 21 2 3 2 8 0 0
Totale 942